HIGHLIGHTS
- who: Yelan Guan from the Wenzhou Medical University, Wenzhou, Zhejiang, China have published the article: The efficacy of small molecule anti-angiogenic drugs in previously treated Thymic carcinoma, in the Journal: (JOURNAL)
- what: The authors provide real-world data relating to the efficacy of antiangiogenic drugs for the treatment of patients with TCs. The analysis showed that apatinib and anlotinib exhibited considerable antitumor activity and durable responses in advanced TCs. This study showed that after reaching a PFS of 13.0 months with apatinib treatment, the patient was switched to anlotinib due to adverse effects . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.